I had the same impression in listening to the call. As huge a fan as I am of IMGG (and I've got the share numbers to prove it) I've still been a skeptic of the idea that this would go to $2 plus; I just haven't been able to get my arms around whether this product, as great as it is, is just a niche product or something that would truly sell on a large scale. There were a couple of things Dean said that have me wondering now: his "tons of demand just waiting for FDA approval" comment while non-specific, seemed from the gut and genuine. And in answering one of the questioners about possible dilution, he made the comment that even fully diluted (i.e., if all 500 million shares were issued) he believes the company is worth "several dollars per share".
Granted this is the CEO talking and by Dean's own admission he will always believe the company is undervalued but...still it all has me thinking that maybe this product really is one that could generate a market cap that big. One thing seems clear to me now: my initial target price of $1 when I bought this early last year is probably too low.
BTW, was anyone else laughing out loud at these rustics that come out and ask him how high the stock price will go? Sheesh!